Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study. Journal of Crohn's and colitis. pp. 811-819. [Online].